Dexcom, Inc., (NASDAQ:DXCM), the global leader in continuous glucose monitoring (CGM) for people with diabetes, has announced opening a global business services (GBS) centre in Vilnius, Lithuania. The new hub is set to open its doors in 2021 and will expand the company’s patient support, customer advocacy and finance and accounting operations in Europe.

The San Diego-based medical device manufacturer will be joining the booming GBS community of Vilnius. Currently, the city is home to more than 80 centres, including those operated by numerous Fortune 500 companies. Lithuania’s capital was picked after a diligent selection process, which involved sorting through a long list of locations throughout central-eastern Europe.

“Vilnius proved to be an exceptionally attractive location in terms of available qualified talent. The multilingualism of the local talent pool was one of the strongest selling points for us, as fluency and language competencies are crucial in serving our customers from all around the world,” said Quentin Blackford, executive vice president, chief operating officer and chief financial officer at Dexcom. “We were also impressed by the excellent support provided by Invest Lithuania, who quickly became a valuable partner for the project.”

The Vilnius office will support Dexcom operations and its customers across the EMEA region. The new branch is set to be multifaceted and will focus on customer and technical support related to Dexcom products and on providing finance and accounting support for the organization, including accounts receivable, accounts payable, payroll, billing and more.